US Bancorp’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

US Bancorp’s Portfolio OXFD Stock Details OXFD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-965	Closed	-$17K	–	4022
2020 Q4	$17K	Hold	965	–	–	﹤0.01%	2996
2020 Q3	$11K	Hold	965	–	–	﹤0.01%	3064
2020 Q2	$13K	Buy	+965	New	+$11.6K	﹤0.01%	3019

US Bancorp's OXFD Position: Q1 2021 in Review

US Bancorp sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q1 2021, closing a stake of 965 shares — an estimated $17K sold.

US Bancorp first reported a position in OXFD in Q2 2020 and held it in 3 quarters. The position peaked at $17K in Q4 2020. 0 funds tracked by Wall St. Rank hold OXFD as of Q1 2021.

US Bancorp reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q1 2021 after selling out during the quarter.
US Bancorp sold 965 Oxford Immunotec Global PLC Ordinary Shares shares in Q1 2021, an estimated $17K.
US Bancorp first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q2 2020 and held it in 3 quarters.
US Bancorp's Oxford Immunotec Global PLC Ordinary Shares position peaked at $17K in Q4 2020.
0 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q1 2021.

Based on US Bancorp's 13F filing for Q1 2021, filed 28 Apr 2021.